about
Risk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysisStructure of tyrosine aminotransferase fromLeishmania infantumNelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotesHIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensisPostgenomic research on leishmaniasis: a critical self-appraisalDifferentiation and gene flow among European populations of Leishmania infantum MON-1.Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha.Inhibitors of Leishmania GDP-mannose pyrophosphorylase identified by high-throughput screening of small-molecule chemical libraryThe Leishmania amazonensis TRF (TTAGGG repeat-binding factor) homologue binds and co-localizes with telomeresNucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters.Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance.Leishmaniasis Vaccine: Where are We Today?Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid.Early clinical manifestations associated with death from visceral leishmaniasis.HIV-1 promotes intake of Leishmania parasites by enhancing phosphatidylserine-mediated, CD91/LRP-1-dependent phagocytosis in human macrophages.Stage-specific differential gene expression in Leishmania infantum: from the foregut of Phlebotomus perniciosus to the human phagocyte.Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.Phylogenetic and evolutionary analysis of Chinese Leishmania isolates based on multilocus sequence typing.First case of visceral leishmaniasis caused by Leishmania martiniquensis.Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.Th1/Th2 cytokine profile in patients coinfected with HIV and Leishmania in Brazil.Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation.Influence of the Microenvironment in the Transcriptome of Leishmania infantum Promastigotes: Sand Fly versus Culture.In vitro infectivity and differential gene expression of Leishmania infantum metacyclic promastigotes: negative selection with peanut agglutinin in culture versus isolation from the stomodeal valve of Phlebotomus perniciosus.Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected PatientsPerceived quality of life among Visceral Leishmaniasis and HIV coinfected migrant male-workers in Northwest Ethiopia: a qualitative study.Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study.Rapid Tests and the Diagnosis of Visceral Leishmaniasis and Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome CoinfectionEfficient one-pot synthesis, molecular docking and in silico ADME prediction of bis-(4-hydroxycoumarin-3-yl) methane derivatives as antileishmanial agents.The relationship between leishmaniasis and AIDS: the second 10 yearsLeishmaniasis: Path toward elimination from the Indian subcontinentMagnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review.Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis.Probing elongating and branching β-D-galactosyltransferase activities in Leishmania parasites by making use of synthetic phosphoglycansThe first case of isolated facial cutanenous leishmaniasis in a Down syndrome infant: a case report and review of the literature.Decreased memory T-cell response and function in human immunodeficiency virus-infected patients with tegumentary leishmaniasis.Human immunodeficiency virus and leishmaniasis.Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia.Case study of a patient with HIV-AIDS and visceral leishmaniasis co-infection in multiple episodes.Clinical Challenges in the Management of Leishmania/HIV Coinfection in a Nonendemic Area: A Case Report.
P2860
Q27024638-BD96723B-520E-4347-972D-03C5B6AC7F4FQ27683739-D2CDA60B-47FB-4E00-BB35-5A9474900A48Q28473470-5CC1BEC7-BA05-43FB-92ED-3CAF02CDFBA2Q28475092-C595FBC4-05BA-4584-A639-58E1876A3623Q28748982-97D77C40-CE54-415C-8382-5AD49074AA7AQ33350238-49DDBAA4-1347-421B-B643-80832B555717Q33452545-3DEF5966-5C88-44E7-9A1D-4F2B1D813BEFQ33531622-3CF8CE3A-678D-4F84-BBE1-2E77FF8ED903Q33575192-9EEB0412-3308-443D-B202-2FE55ED15025Q33753259-55B96D60-A3B9-42D6-9611-F3DD257879D3Q33797823-0C1F5EEC-8E0B-460D-84BB-8A7DB0B322CDQ33929859-34B5960D-B387-431E-A5DB-7A68AD31B1BBQ33973475-75EA2AF7-A693-4183-8770-6C6DEA87DE8FQ34162993-64172236-5BE3-49CA-8F07-3999998D63A9Q34193385-DA3CC726-F7A0-4547-82D1-AA026A2C4F3CQ34374933-2CDA470C-C551-4D6C-9C77-15EAE1808322Q34433975-401E76FB-F431-48C1-B2E6-E45F6AD91E37Q34707035-FCE2C79D-1247-46E0-94FB-3B17C52516B6Q35140425-CFAB92D8-6518-4620-8162-DFEBF79B8731Q35151864-4E0433C9-C870-48CF-B0F3-A6D6076B4D05Q35271085-FAF2E7CC-472A-4969-A5C6-EA103580B937Q35427832-8CE2646A-2E8F-4A6D-A9CB-820B7AB9FB7EQ36013075-8C1A5539-CA5C-4920-BA28-EFB9EB7A1E68Q36024566-127C17BC-39E2-4CDF-9564-884E4D6BDE74Q36210187-35042A54-7D99-4569-9455-3E8A43982D27Q36283504-3FD306FC-1567-4747-BDFA-C5FE31239C78Q36284391-CC8165FA-4E8E-45B8-B818-9B93ECAED9F2Q36436149-3F0A021D-C695-47B1-9E43-F9320A5CE73FQ36519306-F0E912D4-67D0-4310-8494-23672423DD2CQ36538814-D0CAE8F1-9E78-4AFE-B961-792509F594A3Q36651390-4B067789-E8A3-44EF-949B-137D1FE0E97AQ36733559-9BB95A1D-66FE-4282-B7F4-A7BA5D2E854CQ36831544-4DFB607C-4E16-42F5-A37E-29BC6E41DED9Q36860461-8DDC1FC6-CEBA-4090-950F-2EA832D35D4AQ37074359-1B4368CC-189F-4BAB-93CF-0C7EB22A500AQ37684684-8537CBC2-100A-4803-8227-E365262BE393Q37798456-6A82B9D7-AD3F-49BB-852A-764CF0F9B17FQ38603392-EF084ACD-0F99-486E-A283-DD0C52AFE44BQ40228738-881E57B6-234B-4A4A-B684-24DF68EB9125Q42052594-1E8A3817-3AB6-4D28-AD6C-1084911178BD
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Leishmania/HIV co-infections in the second decade.
@ast
Leishmania/HIV co-infections in the second decade.
@en
type
label
Leishmania/HIV co-infections in the second decade.
@ast
Leishmania/HIV co-infections in the second decade.
@en
prefLabel
Leishmania/HIV co-infections in the second decade.
@ast
Leishmania/HIV co-infections in the second decade.
@en
P2093
P1476
Leishmania/HIV co-infections in the second decade.
@en
P2093
Carmen Cañavate
Israel Cruz
Javier Moreno
Javier Nieto
Jorge Alvar
Philippe Desjeux
P304
P407
P577
2006-03-01T00:00:00Z